ENvue Medical (NASDAQ: FEED) announced the appointment of David Johnson as chairman of the board.
Mr. Johnson is a seasoned healthcare executive and board leader with more than 30 years of experience across the medical technology and biotechnology industries. Most recently, he served as chairman of Advanced Medical Balloons (AMB), where he guided the company through its acquisition by Stryker. Mr. Johnson will work alongside ENvue’s CEO, Doron Besser, and the existing leadership team.
In a statement, David Johnson commented, “We believe ENvue is at the forefront of advanced feeding-tube placement technology, which has been validated in the market and extensively used in the clinic across 38 hospitals in the US. In my opinion, the company’s unique feeding tube placement system that utilizes advanced methods of navigation, integrated sensors and body mapping has the potential to dramatically change the current standard of care in our country. I look forward to a successful 2026 and to working with Doron and the management team as they scale ENvue’s platform and execute the company’s next phase of growth. Beyond the strength of the technology, I see a clear opportunity to build ENvue into a leading enteral feeding company through disciplined commercial expansion, broader hospital adoption, and continued platform development.”
Mr. Besser added, “As we prepare to increase the number of hospital centers utilizing our 510(k) FDA-cleared feeding-tube placement system in 2026, I am pleased to welcome David Johnson as chairman of our company. I firmly believe that David’s extensive experience in healthcare and the public markets, as well as a proven leadership, make him an important asset at this critical inflection point. There is currently a high unmet need for innovation in feeding-tube placement to provide a safe and rapid adult patient experience, while we actively pursue additional FDA 510(k) clearances to expand the ENvue platform into neonatal and pediatric populations. We believe our technology is emerging as that solution and the addition of David’s experience will strengthen our board and support the execution of the strategy we are driving to succeed for our shareholders.”
